IOVA Operating Cash Flow Growth
Iovance Biotherapeutics Inc · Operating Cash Flow Growth
IOVA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported12.93%period ending
IOVA TTM Cash from Operations YoY % (74.79% → 12.93%)
Year-over-year change
High-resolution chart · PNG
IOVA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 12.929% | |
| 19.0208% | |
| 14.3264% | |
| 11.1404% | |
| 21.9546% | |
| 12.9831% | |
| 2.444% | |
| -2.2868% | |
| -16.0179% | |
| -20.5521% | |
| -23.5906% | |
| -32.1959% | |
| -27.4197% | |
| -33.1804% | |
| -28.4354% | |
| -13.5782% | |
| -19.7504% | |
| -18.3546% | |
| -11.1181% | |
| -20.6457% | |
| -10.9508% | |
| -3.6609% | |
| -29.1052% | |
| -43.6611% | |
| -61.7586% | |
| -73.4296% | |
| -56.929% | |
| -50.6838% | |
| -45.3541% | |
| -44.6724% | |
| -28.6371% | |
| -29.6979% | |
| -38.7608% | |
| -65.7218% | |
| -140.9361% | |
| -158.0626% | |
| -224.0339% | |
| -140.9272% | |
| -77.727% | |
| -79.1898% | |
| -43.9935% | |
| -98.2216% | |
| -112.9095% | |
| -99.6555% | |
| -107.3788% | |
| -74.517% | |
| -135.7399% | |
| -244.3352% | |
| -216.2776% | |
| -215.5129% | |
| -182.9805% | |
| 205.9513% | |
| 185.3198% | |
| 176.3285% | |
| 171.3067% | |
| -28.6294% | |
| -173.2385% | |
| -465.2086% | |
| -896.9635% | |
| -1,361.4719% | |
| -1,435.9287% | |
| -1,543.6214% | |
| -4,196.8231% | |
| -1,532.416% | |
| -807.9344% | |
| -124.0076% | |
| 74.7867% |